[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100126292":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":26,"centralContacts":30,"locations":36,"responsibleParty":141,"collaborators":145,"id":154,"slug":155,"hasResults":156,"nctId":157,"briefTitle":158,"officialTitle":158,"acronym":159,"eligibilityCriteria":160,"healthyVolunteers":156,"sex":161,"minAge":162,"maxAge":163,"enrollmentInfo":164,"targetDuration":34,"studyType":167,"phases":168,"briefSummary":170,"conditions":171,"keywords":178,"overallStatus":39,"whyStopped":34,"lastUpdateSubmitDate":185,"lastUpdatePostDateStruct":186,"startDateStruct":189,"completionDateStruct":191,"leadSponsor":193,"locationsCount":194},{"fullName":5,"class":6},"Massachusetts General Hospital","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"BrainGate","BrainGate Neural Interface System",[12],"Device: Placement of the BrainGate2 sensor(s) into the motor-related cortex",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"DEVICE","Placement of the BrainGate2 sensor(s) into the motor-related cortex","Up to six 4x4 mm BrainGate2 sensor(s) are placed into the motor-related cortex (including speech-related areas of cortex), connected to one, two, or three percutaneous pedestals. Neural recordings are made at least weekly for a year or more.",[9],[9,20,21,22,23,24,25],"NeuroPort","neural prosthesis","neural prosthetic","neuroprosthetic","brain computer interface","brain-computer interface",[27],{"name":28,"affiliation":5,"role":29},"Leigh R Hochberg, M.D., Ph.D.","PRINCIPAL_INVESTIGATOR",[31],{"name":28,"role":32,"phone":33,"phoneExt":34,"email":35},"CONTACT","617-724-9247",null,"clinicaltrials@braingate.org",[37,57,72,89,109,125],{"facility":38,"status":39,"city":40,"state":41,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"University of California, Davis","RECRUITING","Sacramento","California","95817","United States","US",{"type":46,"coordinates":47},"Point",[48,49],-121.4944,38.58157,{"lat":49,"lon":48},[52,56],{"name":53,"role":32,"phone":54,"phoneExt":34,"email":55},"David M Brandman, MD, PhD","916-703-5010","braingate@ucdavis.edu",{"name":53,"role":29,"phone":34,"phoneExt":34,"email":34},{"facility":58,"status":39,"city":59,"state":41,"zip":60,"country":43,"countryCode":44,"cosmosGeoPoint":61,"geoPoint":65,"contacts":66},"Stanford University School of Medicine","Stanford","94305",{"type":46,"coordinates":62},[63,64],-122.16608,37.42411,{"lat":64,"lon":63},[67,71],{"name":68,"role":32,"phone":69,"phoneExt":34,"email":70},"Jaimie Henderson, M.D.","650-723-5574","henderj@stanford.edu",{"name":68,"role":29,"phone":34,"phoneExt":34,"email":34},{"facility":73,"status":39,"city":74,"state":75,"zip":76,"country":43,"countryCode":44,"cosmosGeoPoint":77,"geoPoint":81,"contacts":82},"Emory University School of Medicine","Atlanta","Georgia","30322",{"type":46,"coordinates":78},[79,80],-84.38798,33.749,{"lat":80,"lon":79},[83,87],{"name":84,"role":32,"phone":85,"phoneExt":34,"email":86},"Yvan Bamps, Ph.D.","404-778-7673","braingate@emory.edu",{"name":88,"role":29,"phone":34,"phoneExt":34,"email":34},"Nicholas Au Yong, M.D., Ph.D.",{"facility":5,"status":39,"city":90,"state":91,"zip":92,"country":43,"countryCode":44,"cosmosGeoPoint":93,"geoPoint":97,"contacts":98},"Boston","Massachusetts","02114",{"type":46,"coordinates":94},[95,96],-71.05977,42.35843,{"lat":96,"lon":95},[99,103,104,107],{"name":100,"role":32,"phone":101,"phoneExt":34,"email":102},"Leigh R Hochberg, MD, PhD","617-742-9247","lhochberg@mgh.harvard.edu",{"name":28,"role":29,"phone":34,"phoneExt":34,"email":34},{"name":105,"role":106,"phone":34,"phoneExt":34,"email":34},"Sydney S Cash, M.D., Ph.D.","SUB_INVESTIGATOR",{"name":108,"role":106,"phone":34,"phoneExt":34,"email":34},"Ziv Williams, M.D., Ph.D.",{"facility":110,"status":39,"city":111,"state":112,"zip":113,"country":43,"countryCode":44,"cosmosGeoPoint":114,"geoPoint":118,"contacts":119},"Providence VA Medical Center","Providence","Rhode Island","02908",{"type":46,"coordinates":115},[116,117],-71.41283,41.82399,{"lat":117,"lon":116},[120,123,124],{"name":121,"role":32,"phone":34,"phoneExt":34,"email":122},"Stephen Mernoff, M.D.","stephen.mernoff@va.gov",{"name":121,"role":29,"phone":34,"phoneExt":34,"email":34},{"name":28,"role":106,"phone":34,"phoneExt":34,"email":34},{"facility":126,"status":39,"city":127,"state":128,"zip":129,"country":43,"countryCode":44,"cosmosGeoPoint":130,"geoPoint":134,"contacts":135},"Baylor College of Medicine","Houston","Texas","77030",{"type":46,"coordinates":131},[132,133],-95.36327,29.76328,{"lat":133,"lon":132},[136,140],{"name":137,"role":32,"phone":138,"phoneExt":34,"email":139},"Sameer Sheth, MD, PhD","832-779-3186","BrainGateStudyBCM@bcm.edu",{"name":137,"role":29,"phone":34,"phoneExt":34,"email":34},{"type":142,"investigatorFullName":143,"investigatorTitle":144,"investigatorAffiliation":5,"oldNameTitle":34,"oldOrganization":34},"SPONSOR_INVESTIGATOR","Leigh R. Hochberg, MD, PhD.","Sponsor-Investigator",[146,149,152],{"name":147,"class":148},"National Institute on Deafness and Other Communication Disorders (NIDCD)","NIH",{"name":150,"class":151},"US Department of Veterans Affairs","FED",{"name":153,"class":148},"National Institute of Neurological Disorders and Stroke (NINDS)","100126292","braingate2-feasibility-study-of-an-intracortical-neural-interface-system-for-persons-with-tetraplegia-100126292",false,"NCT00912041","BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia","BrainGate2","Inclusion Criteria:\n\n* Clinical diagnosis of spinal cord injury, brainstem stroke, muscular dystrophy, amyotrophic lateral sclerosis or other motor neuron disorders\n* Complete or incomplete tetraplegia (quadriplegia)\n* Must live within a three-hour drive of the Study site\n* (There are additional inclusion criteria)\n\nExclusion Criteria:\n\n* Visual impairment such that extended viewing of a computer monitor would be difficult even with ordinary corrective lenses\n* Chronic oral or intravenous steroids or immunosuppressive therapy\n* Other serious disease or disorder that could seriously affect ability to participate in the study\n* (There are additional exclusion criteria)","ALL","18 Years","80 Years",{"count":165,"type":166},27,"ESTIMATED","INTERVENTIONAL",[169],"NA","The purpose of this study is to obtain preliminary device safety information and demonstrate proof of principle (feasibility) of the ability of people with tetraplegia to control a computer cursor and other assistive devices with their thoughts.",[172,173,174,175,176,177],"Tetraplegia","Spinal Cord Injuries","Amyotrophic Lateral Sclerosis","Brain Stem Infarctions","Locked in Syndrome","Muscular Dystrophy",[179,180,181,182,183,184],"Brain computer interface","Assistive device","Environmental control","Communication device","quadriplegia","tetraplegia","2026-05-28",{"date":187,"type":188},"2026-06-01","ACTUAL",{"date":190,"type":34},"2009-05",{"date":192,"type":166},"2038-12",{"name":143,"class":6},6]